T-cell receptor contact and MHC binding residues of a major rye grass pollen allergen T-cell epitope

Citation
Md. Burton et al., T-cell receptor contact and MHC binding residues of a major rye grass pollen allergen T-cell epitope, J ALLERG CL, 103(2), 1999, pp. 255-261
Citations number
34
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
ISSN journal
00916749 → ACNP
Volume
103
Issue
2
Year of publication
1999
Part
1
Pages
255 - 261
Database
ISI
SICI code
0091-6749(199902)103:2<255:TRCAMB>2.0.ZU;2-T
Abstract
Background: T cells are pivotal in the elicitation of allergic diseases. An alogues of T-cell epitope peptides with a modification at a T-cell receptor (TCR) contact site can alter selected T-cell effector functions. Thus the ability to modulate allergen-specific T-cell responses towards T-H1-like by stimulation with peptide analogues may downregulate allergic inflammation. Objectives: The purpose of this study was to characterize the minimal epito pe recognized by cloned T cells of a dominant Lol p 5 epitope, p105-116, an d identify the critical residues involved in TCR and MHC contact. Methods: Using peptides with progressive truncation of N- and C-terminal re sidues in T-cell proliferation assays, we identified the core epitope recog nized by cloned CD4(+) T cells. An additional series of peptides with singl e amino acid substitutions were used in T-cell proliferation and live-cell MHC binding assays. Taken together, these results allowed identification of MHC binding and TCR contact residues of p105-116. Results: The core epitope of p105-116 was identified as residues 107-114. W ithin this core epitope, 3 residues were found to be important for MHC bind ing, positions 107, 110, and 112, whereas those at positions 108, 109, 110, 111, and 113 were putative TCR contact residues. Conclusions: The identification of the TCR and MHC contact residues of a do minant Lol p 5 T-cell epitope and analogues of this peptide capable of modu lating T-cell responses will allow the evaluation of these peptides' potent ial as immunotherapeutic agents for rye grass pollen allergic disease.